Loibl S, Schneeweiss A, Huober J, Braun M, et al. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response. Ann Oncol 2022 Aug 9. pii: S0923-7534(22)03791.
PMID: 35961599